ARTICLE IN ACADEMIC JOURNALS
| NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
|---|---|
| 1. |
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study
2024
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
DOI :
10.1111/apt.17891
|
| 2. |
LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
2024
Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.16675
|
| 3. |
MAFLD in adults: non-invasive tests for diagnosis and monitoring of MAFLD
2024
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY INTERNATIONAL
DOI :
10.1007/s12072-024-10661-x
|
| 4. |
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY INTERNATIONAL
DOI :
10.1007/s12072-024-10702-5
|
| 5. |
Diagnosis and non-invasive assessment of MASLD in type 2 diabetes and obesity
2024
Author(s) : Chan Wah Kheong Source :
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
DOI :
10.1111/apt.17866
|
| 6. |
Correspondence: "A multisociety Delphi consensus statement on new fatty liver disease nomenclature "
2024
Author(s) : Chan Wah Kheong Source :
ANNALS OF HEPATOLOGY
DOI :
10.1016/j.aohep.2024.101485
|
| 7. |
Metabolic fatty liver syndromes: where do we stand in 2024?
2024
Author(s) : Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.16507
|
| 8. |
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease
2024
Author(s) : Chan Wah Kheong Source :
JOURNAL OF HEPATOLOGY
DOI :
10.1016/j.jhep.2023.11.004
|
| 9. |
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
2024
Author(s) : Chan Wah Kheong Source :
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
DOI :
10.1001/jama.2024.1447
|
| 10. |
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease
2024
Author(s) : Chan Wah Kheong Source :
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
DOI :
10.1016/j.hbpd.2023.08.004
|
| 11. |
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis
2024
Author(s) : Chan Wah Kheong Source :
LIVER INTERNATIONAL
DOI :
10.1111/liv.15914
|
| 12. |
Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis
2024
Author(s) : Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.16723
|
| 13. |
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
2024
Author(s) : Chan Wah Kheong Source :
METABOLISM-CLINICAL AND EXPERIMENTAL
DOI :
10.1016/j.metabol.2024.156028
|
| 14. |
Global burden of metabolic diseases, 1990-2021021
2024
Author(s) : Chan Wah Kheong Source :
METABOLISM-CLINICAL AND EXPERIMENTAL
DOI :
10.1016/j.metabol.2024.155999
|
| 15. |
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
2024
Author(s) : Chan Wah Kheong Source :
GUT
DOI :
10.1136/gutjnl-2024-333074
|
| 16. |
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
2024
Author(s) : Chan Wah Kheong Source :
JHEP REPORTS
DOI :
10.1016/j.jhepr.2024.101066
|
| 17. |
Calculated parameters for the diagnosis of Wilson disease
2023
Author(s) : Pavai Sthaneshwar, Chan Wah Kheong Source :
SINGAPORE MEDICAL JOURNAL
DOI :
10.11622/smedj.2022019
|
| 18. |
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial
2023
Author(s) : Chan Wah Kheong, Lim Lee Ling Source :
GUT
DOI :
10.1136/gutjnl-2023-330269
|
| 19. |
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
2023
Source :
ANNALS OF HEPATOLOGY
DOI :
10.1016/j.aohep.2022.100888
|
| 20. |
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY INTERNATIONAL
DOI :
10.1007/s12072-023-10543-8
|
| 21. |
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
2023
Author(s) : Chan Wah Kheong Source :
CLINICS IN LIVER DISEASE
DOI :
10.1016/j.cld.2023.01.019
|
| 22. |
Response to letter to editor: Potential impact of <i>Helicobacter pylori</i> infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B
2023
Author(s) : Chan Wah Kheong Source :
JOURNAL OF VIRAL HEPATITIS
DOI :
10.1111/jvh.13858
|
| 23. |
Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
2023
Source :
HEPATOLOGY INTERNATIONAL
DOI :
10.1007/s12072-023-10550-9
|
| 24. |
Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?
2023
Author(s) : Lim Soo Kun, Chan Wah Kheong Source :
NEPHROLOGY
DOI :
10.1111/nep.14186
|
| 25. |
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH SIGNIFICANT IMPAIRMENT OF WORK PRODUCTIVITY: DATA FROM THE GLOBAL NASH REGISTRY™
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 26. |
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
2023
Author(s) : Chan Wah Kheong Source :
CHINESE MEDICAL JOURNAL
DOI :
10.1097/CM9.0000000000002603
|
| 27. |
Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease
2023
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.16313
|
| 28. |
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
2023
Author(s) : Chan Wah Kheong Source :
JOURNAL OF VIRAL HEPATITIS
DOI :
10.1111/jvh.13800
|
| 29. |
A systematic review on factors associated with non-alcoholic fatty liver disease (NAFLD) among adolescents
2023
Author(s) : Hazreen Bin Abdul Majid, Chan Wah Kheong Source :
CLINICAL NUTRITION ESPEN
DOI :
10.1016/j.clnesp.2023.06.014
|
| 30. |
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
2023
Author(s) : Chan Wah Kheong, Chuah Kee Huat Source :
CLINICAL AND MOLECULAR HEPATOLOGY
DOI :
10.3350/cmh.2022.0426
|
| 31. |
Comparison between obese and non-obese nonalcoholic fatty liver disease
2023
Author(s) : Chan Wah Kheong Source :
CLINICAL AND MOLECULAR HEPATOLOGY
DOI :
10.3350/cmh.2022.0350
|
| 32. |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
2023
Author(s) : Chan Wah Kheong Source :
HEPATOBILIARY SURGERY AND NUTRITION
DOI :
10.21037/hbsn-22-421
|
| 33. |
A GLOBAL SURVEY OF PHYSICIAN KNOWLEDGE ABOUT MANAGEMENT OF CHRONIC HEPATITIS C
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 34. |
Assessing advanced fibrosis in metabolic-associated steatotic liver disease-the MAFLD fibrosis score. Authors' reply
2023
Author(s) : Chan Wah Kheong Source :
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
DOI :
10.1111/apt.17774
|
| 35. |
VALIDATION OF LIVERFAST- GP plus ( GP plus ) AS A NONINVASIVE TEST FOR RISK STRATIFICATION FOR PATIENTS WITH NON- ALCOHOLIC FATTY LIVER DISEASE ( NAFLD): SINGLECENTRE STUDY USING LIVER BIOPSY AS REFERENCE STANDARD.
2023
Author(s) : Chan Wah Kheong, Lai Lee Lee Source :
HEPATOLOGY
|
| 36. |
COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 37. |
SERIAL VIBRATION CONTROLLED TRANSIENT ELASTOGRAPHY (VCTE)-BASED AGILE SCORES PREDICT LIVER-RELATED EVENTS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) - A MULTICENTER COHORT STUDY OF 16,603 PATIENTS
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 38. |
LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 39. |
THE UTILITY OF SEQUENTIAL SAFE SCORE AND FIBROSCAN IN PREDICTING CLINICALLY SIGNIFICANT FIBROSIS IN ASIAN NAFLD PATIENTS.
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 40. |
HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 41. |
NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 42. |
CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD
2023
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY
|
| 43. |
Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
2023
Author(s) : Chan Wah Kheong, Chan Wah Loong Source :
HEPATOBILIARY SURGERY AND NUTRITION
DOI :
10.21037/hbsn-23-346
|
| 44. |
Nonalcoholic Fatty Liver Disease A Unique Entity or Part of the Metabolic Syndrome or Both
2023
Author(s) : Chan Wah Kheong Source :
MEDICAL CLINICS OF NORTH AMERICA
DOI :
10.1016/j.mcna.2022.12.003
|
| 45. |
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease
2023
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
DOI :
10.1111/apt.17722
|
| 46. |
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study
2023
Author(s) : Chan Wah Kheong Source :
JOURNAL OF VIRAL HEPATITIS
DOI :
10.1111/jvh.13796
|
| 47. |
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
2023
Author(s) : Chan Wah Kheong Source :
JOURNAL OF HEPATOLOGY
DOI :
10.1016/j.jhep.2022.10.034
|
| 48. |
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease
2022
Author(s) : Chan Wah Kheong Source :
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1016/j.cgh.2021.06.048
|
| 49. |
Meaning of non-overlapping patients between the MAFLD and NAFLD definitions
2022
Author(s) : Chan Wah Kheong Source :
LIVER INTERNATIONAL
DOI :
10.1111/liv.15142
|
| 50. |
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease
2022
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.15787
|
| 51. |
Asian perspective on NAFLD-associated HCC
2022
Author(s) : Chan Wah Kheong Source :
JOURNAL OF HEPATOLOGY
DOI :
10.1016/j.jhep.2021.09.024
|
| 52. |
Global multi-stakeholder endorsement of the MAFLD definition
2022
Source :
LANCET GASTROENTEROLOGY & HEPATOLOGY
DOI :
10.1016/S2468-1253(22)00062-0
|
| 53. |
Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems
2022
Author(s) : Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.15843
|
| 54. |
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
2022
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
WORLD JOURNAL OF GASTROENTEROLOGY
DOI :
10.3748/wjg.v28.i15.1563
|
| 55. |
Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia
2022
Author(s) : Lim Soo Kun, Chan Wah Kheong Source :
SEMINARS IN DIALYSIS
DOI :
10.1111/sdi.13117
|
| 56. |
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
2022
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY COMMUNICATIONS
DOI :
10.1002/hep4.2048
|
| 57. |
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
2022
Author(s) : Chan Wah Kheong Source :
JOURNAL OF VIRAL HEPATITIS
DOI :
10.1111/jvh.13741
|
| 58. |
Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study
2022
Author(s) : Sanjiv A/l K. Mahadeva, Ida Normiha Binti Hilmi, Chan Wah Kheong, Ho Shiaw Hooi, Chuah Kee Huat Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.15905
|
| 59. |
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
2021
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
DOI :
10.1111/apt.16487
|
| 60. |
Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus
2021
Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.15160
|
| 61. |
Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients
2021
Author(s) : Chan Wah Kheong, Koh Peng Soon Source :
The Medical journal of Malaysia
|
| 62. |
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
2021
Author(s) : Chan Wah Kheong Source :
LANCET GASTROENTEROLOGY & HEPATOLOGY
DOI :
10.1016/S2468-1253(21)00031-5
|
| 63. |
Nonalcoholic Fatty Liver Disease: A Global Perspective
2021
Author(s) : Chan Wah Kheong Source :
CLINICAL THERAPEUTICS
DOI :
10.1016/j.clinthera.2021.01.007
|
| 64. |
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
2021
Author(s) : Chan Wah Kheong Source :
LANCET GASTROENTEROLOGY & HEPATOLOGY
DOI :
10.1016/S2468-1253(20)30357-5
|
| 65. |
Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
2021
Author(s) : Chan Wah Kheong Source :
FRONTIERS IN MEDICINE
DOI :
10.3389/fmed.2021.637652
|
| 66. |
Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease
2021
Source :
Plos One
|
| 67. |
Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients.
2021
Author(s) : Koh Peng Soon, Chan Wah Kheong Source :
MEDICAL JOURNAL OF MALAYSIA
|
| 68. |
Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
2021
Author(s) : Chan Wah Kheong Source :
Frontiers in Medicine
DOI :
10.3389/fmed.2021.637652
|
| 69. |
Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease
2021
Source :
PLOS ONE
DOI :
10.1371/journal.pone.0250300
|
| 70. |
Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
2021
Source :
CLINICAL AND MOLECULAR HEPATOLOGY
DOI :
10.3350/cmh.2020.0162
|
| 71. |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
2021
Author(s) : Chan Wah Kheong Source :
Gut
DOI :
10.1136/gutjnl-2021-324243
|
| 72. |
Allele HLA DQB1* 06 reduces fibrosis score in patients with non alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
Hepatology Research
DOI :
10.1111/hepr.13525
|
| 73. |
Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD
2020
Author(s) : Chan Wah Kheong Source :
J Gastroenterol Hepatol
DOI :
10.1111/jgh.15055
|
| 74. |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020
Source :
Lancet Gastroenterol Hepatol
DOI :
10.1016/S2468-1253(19)30383-8
|
| 75. |
Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease in patient with diabetes mellitus
2020
Author(s) : Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology
|
| 76. |
Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH registry™
2020
Author(s) : Chan Wah Kheong Source :
Hepatology
|
| 77. |
A new definition for metabolic associated fatty liver disease :an international expert consensus statement
2020
Author(s) : Chan Wah Kheong Source :
Journal of Hepatology
DOI :
10.1016/j.jhep.2020.03.039
|
| 78. |
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
2020
Author(s) : Chan Wah Kheong Source :
The Lancet Gastroenterology & Hepatology
DOI :
10.1016/S2468-1253(20)30190-4
|
| 79. |
Unhealthy lifestyle habits and physical inactivity among Asian patients with non alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
Liver International
DOI :
10.1111/liv.14638
|
| 80. |
Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians
2020
Author(s) : Chan Wah Kheong Source :
Hepatology
|
| 81. |
Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one
2020
Author(s) : Sanjiv A/l K. Mahadeva, Shireene Ratna A/p D B Vethakkan, Chan Wah Kheong, Lai Lee Lee, Chuah Kee Huat Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.14978
|
| 82. |
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
HEPATOLOGY INTERNATIONAL
DOI :
10.1007/s12072-020-10094-2
|
| 83. |
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease
2020
Author(s) : Sanjiv A/l K. Mahadeva, Kartini Binti Rahmat, Chan Wah Kheong, Lai Lee Lee, Leong Wai Ling Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.14782
|
| 84. |
The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry™
2020
Author(s) : Chan Wah Kheong Source :
Hepatology
|
| 85. |
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
Hepatology International
DOI :
10.1007/s12072-020-10094-2
|
| 86. |
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
Author(s) : Chan Wah Kheong Source :
BMC Gastroenterology
DOI :
10.1186/s12876-020-01240-z.
|
| 87. |
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
Author(s) : Goh Khean Lee, Chan Wah Kheong Source :
BMC GASTROENTEROLOGY
|
| 88. |
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B
2020
Author(s) : Chan Wah Kheong, Rosmawati Binti Mohamed Source :
Journal of Viral Hepatitis
DOI :
10.1111/jvh.13361
|
| 89. |
Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease
2020
Author(s) : Yang Faridah Binti Abdul Aziz, Sanjiv A/l K. Mahadeva, Anushya A/p Vijayananthan, Kartini Binti Rahmat, Chan Wah Kheong, Lai Lee Lee Source :
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1016/j.cgh.2019.08.023
|
| 90. |
Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
2020
Source :
DIGESTIVE DISEASES AND SCIENCES
DOI :
10.1007/s10620-019-5477-1
|
| 91. |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020
Author(s) : Chan Wah Kheong Source :
LANCET GASTROENTEROLOGY & HEPATOLOGY
DOI :
10.1016/S2468-1253(19)30383-8
|
| 92. |
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
Author(s) : Chan Wah Kheong Source :
BMC GASTROENTEROLOGY
DOI :
10.1186/s12876-020-01240-z
|
| 93. |
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
2020
Author(s) : Chan Wah Kheong Source :
JOURNAL OF HEPATOLOGY
DOI :
10.1016/j.jhep.2020.03.039
|
| 94. |
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2020
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
AMERICAN JOURNAL OF GASTROENTEROLOGY
DOI :
10.14309/ajg.0000000000000588
|
| 95. |
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 96. |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020
Author(s) : Chan Wah Kheong Source :
LANCET GASTROENTEROLOGY HEPATOLOGY
|
| 97. |
Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
2020
Author(s) : Chan Wah Kheong Source :
WORLD JOURNAL OF GASTROENTEROLOGY
DOI :
10.3748/wjg.v26.i19.2416
|
| 98. |
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
2020
Author(s) : Chan Wah Kheong Source :
LANCET GASTROENTEROLOGY & HEPATOLOGY
DOI :
10.1016/S2468-1253(20)30190-4
|
| 99. |
Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease
2020
Author(s) : Rosmawati Binti Mohamed, Zahurin Binti Mohamed, Sanjiv A/l K. Mahadeva, Roma Choudhury Basu, Chan Wah Kheong, Shamsul Bin Mohd Zain, Eng Hooi Sian Source :
HEPATOLOGY RESEARCH
DOI :
10.1111/hepr.13525
|
| 100. |
Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial
2020
Author(s) : Chan Wah Kheong Source :
ENDOSCOPY
DOI :
10.1055/a-1172-6027
|
| 101. |
Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.15055
|
| 102. |
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
LIVER INTERNATIONAL
DOI :
10.1111/liv.14638
|
| 103. |
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B
2020
Author(s) : Rosmawati Binti Mohamed, Chan Wah Kheong Source :
JOURNAL OF VIRAL HEPATITIS
DOI :
10.1111/jvh.13361
|
| 104. |
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
2020
Author(s) : Chan Wah Kheong Source :
SEMINARS IN LIVER DISEASE
DOI :
10.1055/s-0040-1713006
|
| 105. |
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease
2020
Author(s) : Sanjiv A/l K. Mahadeva, Anushya A/p Vijayananthan, Kartini Binti Rahmat, Chan Wah Kheong, Lai Lee Lee, Leong Wai Ling Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.14782
|
| 106. |
Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
2020
Source :
DIGESTIVE DISEASES AND SCIENCES
DOI :
10.1007/s10620-019-5477-1
|
| 107. |
Positive Hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source :
Am J Gastroenterol
DOI :
10.14309/ajg.00(13)588
|
| 108. |
Epidemiology of non-alcoholic fatty liver disease in Asia Indian Journal of Gastroenterology
2020
Source :
Indian Journal of Gastroenterology
|
| 109. |
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
2020
Author(s) : Chan Wah Kheong Source :
Seminars in Liver Disease
DOI :
10.1055/s-0040-1713006
|
| 110. |
Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial
2020
Author(s) : Chan Wah Kheong Source :
Endoscopy
DOI :
10.1055/a-1172-6027
|
| 111. |
Liver stiffness measurement in non alcoholic fatty liver disease: two is better than one
2020
Author(s) : Lai Lee Lee, Shireene Ratna A/p D B Vethakkan, Chuah Kee Huat, Chan Wah Kheong, Sanjiv A/l K. Mahadeva Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
DOI :
10.1111/jgh.14978
|
| 112. |
Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry
2020
Author(s) : Chan Wah Kheong Source :
Hepatology
|
| 113. |
Use of simple scoring systems for a public health approach in the management of non alcoholic fatty liver disease patients
2020
Author(s) : Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology Open
DOI :
10.1002/jgh3.12414
|
| 114. |
Volumetric liver fat fraction determines grade of steatosis more accurately than controlled attenuation parameter in patients with nonalcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source :
Clinical Gastroenterology and Hepatology
DOI :
https://doi.org/10.1016/j.cgh.2019.08.023
|
| 115. |
MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong Source :
Liver International
|
| 116. |
Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
2019
Author(s) : Chan Wah Kheong, Shireene Ratna A/p D B Vethakkan Source :
Digestive Diseases and Sciences
|
| 117. |
Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance
2019
Author(s) : Chuah Kee Huat, Chan Wah Kheong Source :
Current Hepatology Reports
DOI :
10.1007/s11901-019-00493-x
|
| 118. |
Epidemiological differences of common liver conditions between Asia and the West
2019
Author(s) : Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology
DOI :
10.1002/jgh3.12275
|
| 119. |
Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong Source :
Liver International
|
| 120. |
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in nonalcoholic fatty liver disease.
2019
Author(s) : Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology
|
| 121. |
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology
|
| 122. |
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis.
2019
Author(s) : Chan Wah Kheong Source :
Clinical Gastroenterology and Hepatology
|
| 123. |
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.
2019
Author(s) : Chan Wah Kheong Source :
Gut
|
| 124. |
Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source :
Clinical Gastroenterology and Hepatology
DOI :
https://doi.org/10.1016/j.cgh.2019.09.027
|
| 125. |
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
2019
Author(s) : Goh Khean Lee, Chan Wah Kheong Source :
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 126. |
Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong, Pavai Sthaneshwar Source :
JGH Open
|
| 127. |
A new bile acid treatment for non-alcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source :
Lancet Gastroenterology and Hepatology
|
| 128. |
Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community
2018
Author(s) : Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology Open
DOI :
10.1002/jgh3.12114
|
| 129. |
Hepatitis B virus infection among children of hepatitis B surface
antigen positive mothers in a Malaysian hospital.
2018
Author(s) : Chan Wah Kheong Source :
Medical Journal of Malaysia
|
| 130. |
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease.
2018
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
Hepatology International
DOI :
https://doi.org/10.1007/s12072-018-9843-4
|
| 131. |
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography
2018
Author(s) : Shireene Ratna A/p D B Vethakkan, Chan Wah Kheong Source :
Journal of Gastroenterology and Hepatology
DOI :
10.1111/jgh.14577
|
| 132. |
Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
2018
Author(s) : Chan Wah Kheong Source :
JGH Open
|
| 133. |
Clinical features and treatment of non-alcoholic fatty liver disease across the Asia Pacific region – the GO ASIA initiative
2018
Author(s) : Chan Wah Kheong Source :
Alimentary Pharmacology and Therapeutics
|
| 134. |
Endoscopic Management of Colonoscopy‑related Perforation
2018
Author(s) : Chan Wah Kheong Source :
Journal of Digestive Endoscopy
DOI :
10.4103/jde.JDE_74_17
|
| 135. |
Impact of Controlled Attenuation Parameter on Detecting Fibrosis using Liver Stiffness Measurement
2018
Author(s) : Chan Wah Kheong Source :
Alimentary Pharmacology and Therapuetics
|
| 136. |
Editorial: NAFLD in Asia – clinical associations with advanced disease become clearer – Authors’ reply.
2018
Author(s) : Chan Wah Kheong Source :
Alimentary Pharmacology & Therapeutics
|
| 137. |
Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
2018
Author(s) : Chan Wah Kheong, Sanjiv A/l K. Mahadeva Source :
Journal of Gastroenterology and Hepatology
|
| 138. |
Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis.
2017
Author(s) : Chan Wah Kheong, Sanjiv A/l K. Mahadeva Source :
J Hepatol
DOI :
10.1016/j.jhep.2016.12.022.
|
| 139. |
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.
2017
Author(s) : Sanjiv A/l K. Mahadeva, Chan Wah Kheong Source :
Clin Gastroenterol Hepatol
DOI :
10.1016/j.cgh.2017.04.016.
|
| 140. |
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease
2017
Source :
PLOS ONE
DOI :
10.1371/journal.pone.0174982
|
| 141. |
Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease.
2017
Author(s) : Chan Wah Kheong Source :
Hepatobiliary Surgery and Nutrition
DOI :
10.21037/hbsn.2017.03.06
|
| 142. |
Endoscopic sleeve gastroplasty: case report, technique and literature review.
2017
Author(s) : Chan Wah Kheong Source :
Journal of Digestive Diseases
|
| 143. |
Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.
2017
Author(s) : Chan Wah Kheong Source :
United European Gastroenterology Journal
DOI :
10.1177/2050640616646528
|
| 144. |
The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups.
2017
Author(s) : Chan Wah Kheong Source :
J Gastroenterol Hepatol
|
| 145. |
The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.
2017
Author(s) : Chan Wah Kheong Source :
J Gastroenterol Hepatol
|
| 146. |
Enteropathy-associated T-cell lymphoma: An extremely rare cause of chronic diarrhoea.
2016
Author(s) : Chan Wah Kheong, Koh Peng Soon Source :
Medical Journal of Malaysia
|
| 147. |
Asian Consensus on the Relationship between Obesity and Gastrointestinal and Liver Diseases.
2016
Author(s) : Chan Wah Kheong Source :
J Gastroenterol Hepatol
DOI :
10.1111/jgh.13385
|
| 148. |
Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.
2016
Author(s) : Chan Wah Kheong Source :
J Gastroenterol Hepatol
DOI :
10.1111/jgh.13381
|
| 149. |
Split-dose low volume bowel preparation, a feasible option for preparation for colonoscopy.
2016
Author(s) : Chan Wah Kheong Source :
Endoscopy
|
| 150. |
Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non- alcoholic fatty liver disease.
2015
Author(s) : Chan Wah Kheong Source :
Scientific Reports
|
| 151. |
A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis
2015
Author(s) : Chan Wah Kheong Source :
Hepatology International
|
| 152. |
Low physical activity and energy dense Malaysian foods are associated with non- alcoholic fatty liver dis-ease in centrally obese but not in non-centrally obese patients with diabetes mellitus
2015
Author(s) : Chan Wah Kheong Source :
Asia Pac J Clin Nutr
|
| 153. |
Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy.
2015
Author(s) : Chan Wah Kheong Source :
Journal of Digestive Diseases
|
| 154. |
Narrow-band imaging and white-light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett s esophagus: results of the Asia-Pacific Barrett s Consortium
2015
Author(s) : Chan Wah Kheong Source :
Endoscopy International Open
|
| 155. |
Progression of non-alcoholic fatty liver disease a prospective clinicopathological follow-up study
2014
Author(s) : Chan Wah Kheong Source :
Journal of Digestive Diseases
|
| 156. |
Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population.
2014
Author(s) : Chan Wah Kheong Source :
Clinics and Research in Hepatology and Gastroenterology
|
| 157. |
Controlled attenuation parameter for detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
| 158. |
Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy
2014
Author(s) : Chan Wah Kheong Source :
World Journal of Gastroenterology
|
| 159. |
Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.
2014
Author(s) : Chan Wah Kheong Source :
Hepatology International
|
| 160. |
Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease
2014
Author(s) : Sanjay Rampal A/l Lekhraj Rampal, Zahurin Binti Mohamed, Cheah Phaik Leng, Shamsul Mohd Zain, Rosmawati Binti Mohamed, Chan Wah Kheong Source :
PLOS ONE
|
| 161. |
Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2014
Author(s) : Chan Wah Kheong Source :
Plos One
|
| 162. |
Clinical outcomes and direct costing of endoluminal clipping compared to surgery in the management of iatrogenic colonic perforation.
2013
Source :
Journal of Digestive Diseases
DOI :
10.1111/1751-2980.12097
|
| 163. |
Epidemiology of a Fast-Emerging Disease in the Asia Pacific Region - Non-Alcoholic Fatty Liver Disease (NAFLD).
2013
Author(s) : Chan Wah Kheong Source :
Hepatology International
|
| 164. |
Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetics Prevalence and Predictive Factors in a Multi-Racial Hospital Clinic Population in Malaysia
2013
Author(s) : Chan Wah Kheong Source :
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 165. |
Cyclosporine Rescue Therapy in Autoimmune Liver
Cirrhosis: A Case Report.
2012
Author(s) : Chan Wah Kheong Source :
Turkish Journal of Gastroenterology
|
| 166. |
Evaluation of Patient Satisfaction of an Outpatient
Colonoscopy Service in an Asian Tertiary Care
Hospital.
2012
Author(s) : Chan Wah Kheong |
| 167. |
Evaluation of patient satisfaction of an outpatient
gastroscopy service in an Asian tertiary care hospital.
2012
Author(s) : Chan Wah Kheong Source :
BMC Gastroenterology
|
| 168. |
Commentary: changing aetiology of peptic ulcers.
2012
Author(s) : Chan Wah Kheong Source :
Alimentary Pharmacology and Therapeutics
|
| 169. |
A validation study of the Leeds Dyspepsia
Questionnaire
in a multi-ethnic Asian population.
2011
Author(s) : Chan Wah Kheong Source :
J Gastroenterol Hepatol
|
| 170. |
Appointment waiting times and education level
influence the quality of bowel preparation in
adult patients undergoing colonoscopy.
2011
Author(s) : Chan Wah Kheong Source :
BMC Gastroenterology
|
| 171. |
Epidemiology of Helicobacter pylori Infection and
Public Health Implications
2011
Author(s) : Chan Wah Kheong Source :
Helicobacter
|
CHAPTER IN BOOK
| NO | DETAILS OF CHAPTER IN BOOK |
|---|
PROCEEDING
| NO | DETAILS OF PROCEEDING |
|---|---|
| 1. |
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
2021
Author(s) : Chan Wah Kheong |
| 2. |
The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry
2021
Author(s) : Chan Wah Kheong |
| 3. |
The spectrum of gastrointestinal and liver diseases has an ethnic predilection: observations from a specialist clinic in Malaysia
2021
Author(s) : Chan Wah Kheong |
| 4. |
Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis
2021
Author(s) : Chan Wah Kheong |
| 5. |
Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia.
2021
Author(s) : Chan Wah Kheong |
| 6. |
Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease
2021
Author(s) : Chan Wah Kheong |
| 7. |
Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia.
2021
Author(s) : Chan Wah Kheong |
| 8. |
Concordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia
2020
Author(s) : Chan Wah Kheong |
| 9. |
Prescription of Statin and Low-Density Lipoprotein Cholestrol Treatment Targets in Non-Alcoholic Fatty Liver Disease Petients
2019
Author(s) : Chan Wah Kheong |
| 10. |
Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients.
2019
Author(s) : Chan Wah Kheong |
| 11. |
Fibroscan as a Non-Invasive Approach to Predict the Presence and Size of Varices in the Malaysian Cirrhotic Population
2019
Author(s) : Chan Wah Kheong |
| 12. |
Liver Stiffness Measurement in Non-Alcoholic Fatty Liver Disease: Two is Better than One
2019
Author(s) : Chan Wah Kheong |
| 13. |
Non-Invasive Scoring Systems for the Diagnosis of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) in a Malaysian Cahort
2019
Author(s) : Chan Wah Kheong |
| 14. |
MACK-3 (Combination of HOMA, AST, CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong |
| 15. |
Screening for Non-alcoholic Fatty Liver Disease and Advance Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Using Controlled Attenuation Parameter and Liver Stiffness Measurements
2018
Author(s) : Chan Wah Kheong |
| 16. |
Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial
2018
Author(s) : Chan Wah Kheong |
| 17. |
Comparing Shear Wave Elastography and Transient Elastography for the Diagnosis of Fibrosis Stages in Patients with Non-alcoholic Fatty Liver Disease Using Liver Biopsy as the Reference Standard
2018
Author(s) : Chan Wah Kheong |
| 18. |
Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard
2018
Author(s) : Chan Wah Kheong |
| 19. |
Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study.
2018
Author(s) : Chan Wah Kheong |
| 20. |
Empagliflozin for the treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus
2018
Author(s) : Chan Wah Kheong |
| 21. |
Current Therapies - What Has Promise? What Does Not?
2018
Author(s) : Chan Wah Kheong |
| 22. |
Direct Acting Anti-Viral (DAA) in Hepatitis C Virus (HCV) Patients: Early Real-World Data From Malaysia.
2018
Author(s) : Chan Wah Kheong |
| 23. |
A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus
2018
Author(s) : Chan Wah Kheong |
| 24. |
A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology
2018
Author(s) : Chan Wah Kheong |
| 25. |
A Comparison of the Hepafat-Scan and Fibroscan Controlled Attenuation Parameter in the Estimation of Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease Using Histology as the Reference Standard
2018
Author(s) : Chan Wah Kheong |
| 26. |
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in nonalcoholic fatty liver disease
2017
Author(s) : Chan Wah Kheong |
| 27. |
The high prevalence and predictors of advance fibrosis in elderly patients with liver biopsy confirmed non-alcoholic fatty liver disease (NAFLD)-The GOASIA STUDY.
2017
Author(s) : Chan Wah Kheong |
| 28. |
Perception and bariatric practices of obesity-related gastrointestinal (GI) disease among Asian GI practitioners: GOASIA working group initiative
2017
Author(s) : Chan Wah Kheong |
| 29. |
Comparing the BCLC and HKLC staging systems in the management of hepatocellular carcinoma in a tertiary center in Malaysia
2017
Author(s) : Chan Wah Kheong |
| 30. |
Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?
2017
Author(s) : Chan Wah Kheong |
| 31. |
Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan®)?
2017
Author(s) : Chan Wah Kheong |
| 32. |
A Substantial Proportion of Patients with Chronic Hepatitis B have Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study Using FibroScan at Major Tertiary Hospital in Malaysia
2017
Author(s) : Chan Wah Kheong |
| 33. |
Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience
2017
Author(s) : Chan Wah Kheong |
| 34. |
Management of NAFLD – case discussion
2017
Author(s) : Chan Wah Kheong |
| 35. |
Non-alcoholic fatty liver disease- demographic features, risk factors and treatment practices across the Asia Pacific region-the GOASIA initiative
2017
Author(s) : Chan Wah Kheong |
| 36. |
Non-alcoholic fatty liver disease demographic features, risk factors and treatment practices across the Asia Pacific region the GO ASIA initiative
2017
Author(s) : Chan Wah Kheong |
| 37. |
A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort
2016
Author(s) : Chan Wah Kheong |
| 38. |
Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Ballooning and Adult NAFLD Patients: Non-invansive Biomarkers in Diagnosis of Non-Alcoholic Steatohapetitis (NASH) in Adult Patients
2016
Author(s) : Chan Wah Kheong |
| 39. |
Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study
2016
Author(s) : Chan Wah Kheong |
| 40. |
New Therapeutic Options for NAFLD
2016
Author(s) : Chan Wah Kheong |
| 41. |
Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis
2016
Author(s) : Chan Wah Kheong |
| 42. |
A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia
2016
Author(s) : Chan Wah Kheong |
| 43. |
An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative
2016
Author(s) : Chan Wah Kheong |
| 44. |
Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study
2016
Author(s) : Chan Wah Kheong |
| 45. |
Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia
2016
Author(s) : Chan Wah Kheong |
| 46. |
Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis
2016
Author(s) : Chan Wah Kheong |
| 47. |
Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients
2016
Author(s) : Chan Wah Kheong |
| 48. |
A Study of Non-Alcoholic Fatty Liver Disease Using Transient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-aged Malaysian Population
2016
Author(s) : Chan Wah Kheong |
| 49. |
A randomized double-blind, placebo-controlled trial of silymarin for the treatment of non-alcoholic steatohepatitis
2016
Author(s) : Chan Wah Kheong |
| 50. |
Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease?
2015
Author(s) : Chan Wah Kheong |
| 51. |
Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2015
Author(s) : Chan Wah Kheong |
| 52. |
Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease?
2015
Author(s) : Chan Wah Kheong |
| 53. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
| 54. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
| 55. |
A novel 2 step approach combining the nafld fibrosis score and liver stiffness measurement for predicting advanced fibrosis
2015
Author(s) : Chan Wah Kheong |
| 56. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
| 57. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
| 58. |
Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
| 59. |
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
| 60. |
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
| 61. |
Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2014
Author(s) : Chan Wah Kheong |
| 62. |
Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
| 63. |
Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2014
Author(s) : Chan Wah Kheong |
| 64. |
Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long-standing poorly controlled diabetics.
2013
Author(s) : Chan Wah Kheong |
| 65. |
Ultrasonography-diagnosed NAFLD is not associated with IHD among long-standing poorly-controlled diabetics
2013
Author(s) : Chan Wah Kheong |
| 66. |
Prevalence of NAFLD and associated factors among multi- racial Malaysian population.
2013
Author(s) : Chan Wah Kheong |
| 67. |
Reduced-volume PEG-ELS plus bisacodyl split- dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study
2013
Author(s) : Chan Wah Kheong |
| 68. |
Split versus whole-dose PEG-ELS for bowel preparation in outpatient colonoscopy.
2013
Author(s) : Chan Wah Kheong |
| 69. |
Non-alcoholic fatty liver disease in young adults � worrying ethnic differences in a multi-racial Asian population in Malaysia
2013
Author(s) : Chan Wah Kheong |
| 70. |
Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics
2013
Author(s) : Chan Wah Kheong |
| 71. |
Progression of non-alcoholic fatty liver disease (NAFLD) � a prospective clinicopathological follow-up study
2013
Author(s) : Chan Wah Kheong |
| 72. |
Clinical and histological follow-up of a cohort of patients with NAFLD.
2012
Author(s) : Chan Wah Kheong |
| 73. |
Prevalence of NAFLD among diabetic patients in the outpatient clinic of a Malaysian hospital and associated factors.
2012
Author(s) : Chan Wah Kheong |
| 74. |
Endoluminal clipping versus surgery in the management of iatrogenic colonic perforation: a direct cost analysis.
2012
Author(s) : Chan Wah Kheong |
| 75. |
The role of diet and physical activity in non-alcoholic fatty liver disease (NAFLD) in diabetic patients.
2012
Author(s) : Chan Wah Kheong |
| 76. |
Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre endoscopy unit.
2011
Author(s) : Chan Wah Kheong |
| 77. |
Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital.
2011
Author(s) : Chan Wah Kheong |
| 78. |
Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital.
2011
Author(s) : Chan Wah Kheong |
| 79. |
Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit.
2011
Author(s) : Chan Wah Kheong |
| 80. |
Risk factors for poor bowel preparation and its impact on technical performance and patient. comfort in an Asian population
2010
Author(s) : Chan Wah Kheong |
| 81. |
Patient satisfaction with various aspects of an outpatient colonoscopy service.
2010
Author(s) : Chan Wah Kheong |
RESEARCH COLLABORATOR
| GRANT | PROGRESS | STATUS |
|---|